You just read:

Aridis Pharmaceuticals Announces Publication of Positive AR-301 Phase 1/2a Data in "Intensive Care Medicine" and "The Lancet Respiratory Medicine"

News provided by

Aridis Pharmaceuticals, Inc.

Nov 07, 2018, 07:30 ET